Hematologic Abnormalities and Acute Myeloid Leukemia in Children and Adolescents Administered Intensified Chemotherapy for the Ewing Sarcoma Family of Tumors

Random-Effects Models for Longitudinal Data

1982 • 8,551 citations

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

1988 • 4,727 citations

Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia

1991 • 723 citations

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

1986 • 704 citations

Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer

1992 • 442 citations

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1991 • 373 citations

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.

1996 • 363 citations

Leukemia After Therapy With Alkylating Agents for Childhood Cancer2

1987 • 356 citations

Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia

1990 • 288 citations

Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.

1993 • 269 citations

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

1994 • 267 citations

Radiation-induced genomic instability and persisting oxidative stress in primary bone marrow cultures

1996 • 263 citations

Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents.

1992 • 224 citations

Risk of Acute Nonlymphocytic Leukemia and Preleukemia in Patients Treated with Cyclophosphamide for Non-Hodgkin's Lymphomas

1985 • 210 citations

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.

1994 • 198 citations

Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.

1993 • 193 citations

mcl-1 Is an Immediate-Early Gene Activated by the Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Signaling Pathway and Is One Component of the GM-CSF Viability Response

1998 • 191 citations

Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.

1993 • 186 citations

Therapy‐related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks

1994 • 182 citations

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.

1995 • 168 citations

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.

1992 • 133 citations

Chemotherapy Dose-Intensification for Pediatric Patients With Ewing's Family of Tumors and Desmoplastic Small Round-Cell Tumors: A Feasibility Study at St. Jude Children's Research Hospital

1999 • 125 citations

A primary stem cell lesion in experimental chronic hypoplastic marrow failure

1975 • 123 citations

Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.

1992 • 103 citations

Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways

1998 • 103 citations

Revised classification of acute myeloid leukemia.

1996 • 100 citations

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.

1998 • 80 citations

Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung.

1984 • 80 citations

Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low‐dose etoposide on intergroup rhabdomyosarcoma study III: An interim report

1994 • 76 citations

Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung

1985 • 74 citations

Classification and morphologic features of the myelodysplastic syndromes.

1992 • 66 citations

Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay

1993 • 41 citations

Children in long‐term remission after treatment for acute lymphoblastic leukaemia show persisting haemopoietic injury in clonal and long‐term cultures

1989 • 32 citations

Involvement of the bone marrow stroma in the residual hematopoietic damage induced by irradiation of adult and young mice.

1994 • 25 citations

Long-term bone-marrow damage in children treated for all: Evidence from in vitro colony assays (GM-CFC and CFUF)

1982 • 23 citations

Myelodysplasia and leukaemia related to chemotherapy and/or radiotherapy-a haematological study of 13 cases. Value of macrocytosis as an early sign of bone marrow injury

1980 • 21 citations

The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function

1990 • 19 citations

A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide

1986 • 15 citations

Long-term perturbation of hemopoiesis after moderate damage to stem cells.

1985 • 11 citations